Prevalence of hyperprolactinaemia in female premenopausal blood donors

Clinical Endocrinology

Volumn 79, Issue 4, 2013, Pages 545-549

  Alpañés, Macarena ^a,b   Sanchõn, Raúl ^a   Martínez García, Ma Ángeles ^a,c   Martínez Bermejo, Elena ^a   Escobar Morreale, Héctor F ^a,c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CONTRACEPTIVE AGENT; ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROTROPIN;

ACNE; ADULT; ALOPECIA; AMENORRHEA; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BIRTH CONTROL; BLOOD DONOR; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HIRSUTISM; HORMONAL CONTRACEPTION; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENSTRUATION DISORDER; OLIGOMENORRHEA; PHYSICAL EXAMINATION; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; REPRODUCTIVE HISTORY; STRESS; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TRANSDERMAL PATCH; VAGINA RING;

ADOLESCENT; ADULT; ANDROSTENEDIONE; BLOOD DONORS; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYPERPROLACTINEMIA; PREMENOPAUSE; PREVALENCE; PROLACTIN; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; THYROTROPIN; YOUNG ADULT;

EID: 84883497449     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12182     Document Type: Article

References (29)

1. Melmed, S., (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. Journal of Clinical Investigation, 112, 1603-1618.
2. Malarkey, W.B., Hall, J.C., Pearl, D.K., et al,. (1991) The influence of academic stress and season on 24-hour concentrations of growth hormone and prolactin. Journal of Clinical Endocrinology and Metabolism, 73, 1089-1092.
3. Tyson, J.E., Hwang, P., Guyda, H., et al,. (1972) Studies of prolactin secretion in human pregnancy. American Journal of Obstetrics and Gynecology, 113, 14-20.
4. Kruger, T.H., Leeners, B., Naegeli, E., et al,. (2012) Prolactin secretory rhythm in women: immediate and long-term alterations after sexual contact. Human Reproduction, 27, 1139-1143.
5. Weitzman, R.E., Leake, R.D., Rubin, R.T., et al,. (1980) The effect of nursing on neurohypophyseal hormone and prolactin secretion in human subjects. Journal of Clinical Endocrinology and Metabolism, 51, 836-839.
6. Kleinberg, D.L., Noel, G.L., &, Frantz, A.G., (1977) Galactorrhoea: a study of 235 cases, including 48 with pituitary tumors. New England Journal of Medicine, 296, 589-600.
7. Fearrington, E.L., Rand, C.H. Jr, &, Rose, J.D., (1983) Hyperprolactinaemia-galactorrhoea induced by verapamil. American Journal of Cardiology, 51, 1466-1467.
8. Johnsen, E., Kroken, R.A., Abaza, M., et al,. (2008) Antipsychotic- induced hyperprolactinaemia: a cross-sectional survey. Journal of Clinical Psychopharmacology, 28, 686-690.
9. Hekimsoy, Z., Kafesciler, S., Guclu, F., et al,. (2010) The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism. Endocrine Journal, 57, 1011-1015.
10. Lim, V.S., Kathpalia, S.C., &, Frohman, L.A., (1979) Hyperprolactinaemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation. Journal of Clinical Endocrinology and Metabolism, 48, 101-107.
11. Gomez, F., Reyes, F.I., &, Faiman, C., (1977) Nonpuerperal galactorrhoea and hyperprolactinaemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. American Journal of Medicine, 62, 648-660.
12. De Schepper, J., Schiettecatte, J., Velkeniers, B., et al,. (2003) Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. European Journal of Endocrinology, 149, 201-207.
13. Smith, T.P., Suliman, A.M., Fahie-Wilson, M.N., et al,. (2002) Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. Journal of Clinical Endocrinology and Metabolism, 87, 5410-5415.
14. Souter, I., Baltagi, L.M., Toth, T.L., et al,. (2010) Prevalence of hyperprolactinaemia and abnormal magnetic resonance imaging findings in a population with infertility. Fertility and Sterility, 94, 1159-1162.
15. Sanchon, R., Gambineri, A., Alpanes, M., et al,. (2012) Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Human Reproduction, 27, 1209-1216.
16. Hatch, R., Rosenfield, R.L., Kim, M.H., et al,. (1981) Hirsutism: implications, aetiology, and management. American Journal of Obstetrics and Gynecology, 140, 815-830.
17. Vermeulen, A., Verdonck, L., &, Kaufman, J.M., (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism, 84, 3666-3672.
18. Escobar-Morreale, H.F., (2004) Macroprolactinemia in women presenting with hyperandrogenic symptoms: implications for the management of polycystic ovary syndrome. Fertility and Sterility, 82, 1697-1699.
19. Fernandez, A., Karavitaki, N., &, Wass, J.A., (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clinical Endocrinology, 72, 377-382.
20. Hattori, N., Ishihara, T., &, Saiki, Y., (2009) Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clinical Endocrinology, 71, 702-708.
21. Alfonso, A., Rieniets, K.I., &, Vigersky, R.A., (2006) Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinaemia. Endocrine Practice, 12, 275-280.
22. Bjoro, T., Morkrid, L., Wergeland, R., et al,. (1995) Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scandinavian Journal of Clinical and Laboratory Investigation, 55, 139-147.
23. Fahie-Wilson, M.N., &, Soule, S.G., (1997) Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Annals of Clinical Biochemistry, 34 (Pt 3), 252-258.
24. Leslie, H., Courtney, C.H., Bell, P.M., et al,. (2001) Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. Journal of Clinical Endocrinology and Metabolism, 86, 2743-2746.
25. Olukoga, A.O., &, Kane, J.W., (1999) Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clinical Endocrinology, 51, 119-126.
26. Clemens, J.A., &, Meites, J., (1971) Neuroendocrine status of old constant-estrous rats. Neuroendocrinology, 7, 249-256.
27. Brawer, J.R., Naftolin, F., Martin, J., et al,. (1978) Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology, 103, 501-512.
28. Jaques, S. Jr, &, Gala, R.R., (1979) The influence of oestrogen administration in vivo on in vitro prolactin release. Interaction between dopamine and thyrotrophin releasing hormone. Acta Endocrinologica, 92, 437-447.
29. Asuncion, M., Calvo, R.M., San Millan, J.L., et al,. (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism, 85, 2434-2438.